Glycostem CDO Volker Huppert will be speaking at Cell Series UK conference on 7^th - 8^th November, 2022.

Glycostem to participate 22nd Annual Biotech in Europe Forum (BEF), in-person event on 21^st-22^nd of September 2022 at Basel, Switzerland.

Glycostem will participate EHA2022 Congress in Vienna from 9^th to 12^th June 2022.

Glycostem is going to participate Advanced Therapies Congress in London on 24^th May, 2022. Meet us in the following session:

Time: 14:10 GMT +1 
Presentation: Manufacturing genetically modified NK cells

Glycostem Chief Development Officer Volker Huppert is going to present at the 2022 BioProcess International Europe on 17^th May, 2022.

Presentation title: Platform Approaches for Process Understanding Across Different Biopharmaceutical Sectors: Varying Starting Raw Material in ATMP Processes
Session: Cell & Gene Therapy
Time and date: Tuesday, 17^th May 2022 14:15 - 14:45 CET

Glycostem is attending Bio€quity Europe 2022, from the 16^th - 18^th May 2022.

To book one-to-one partnering meeting with our CEO Troels Jordansen, search "Glycostem" in the partnering platform.